SEC Form DEFA14A filed by Emergent BioSolutions Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
Emergent BioSolutions Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
On April 16, 2026, Emergent BioSolutions Inc. sent the following message to its employees.
Annual Meeting of Stockholders Coming Up, A Reminder to Vote
The 2026 annual meeting of Emergent stockholders will be April 29, 9 a.m. Eastern Time.
The big picture: If you are an eligible shareholder (vested shares as of March 6, 2026), be sure to vote.
| • | Even if you can’t attend the virtual meeting, you can still vote by proxy. |
What’s next: Look for an E*TRADE email with details on how to vote.
| • | Search your inbox for the email from id@proxyvote.com. |
If you’re having trouble with account access, contact customer service.